A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 11,700 shares of ANIP stock, worth $634,257. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,700
Previous 12,400 5.65%
Holding current value
$634,257
Previous $789,000 11.53%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$54.33 - $65.72 $8.78 Million - $10.6 Million
161,538 Added 43.86%
529,877 $31.6 Million
Q2 2024

Aug 14, 2024

BUY
$58.53 - $68.82 $14.6 Million - $17.2 Million
249,573 Added 210.14%
368,339 $23.5 Million
Q1 2024

May 15, 2024

SELL
$54.2 - $69.69 $2.99 Million - $3.85 Million
-55,230 Reduced 31.74%
118,766 $8.21 Million
Q4 2023

Feb 14, 2024

BUY
$48.72 - $65.43 $6.1 Million - $8.19 Million
125,166 Added 256.33%
173,996 $9.59 Million
Q3 2023

Nov 14, 2023

BUY
$50.28 - $64.61 $128,063 - $164,561
2,547 Added 5.5%
48,830 $2.84 Million
Q2 2023

Aug 14, 2023

BUY
$37.29 - $53.83 $1.71 Million - $2.47 Million
45,915 Added 12476.9%
46,283 $2.49 Million
Q1 2023

May 15, 2023

BUY
$37.61 - $45.72 $1,692 - $2,057
45 Added 13.93%
368 $14,000
Q4 2022

Feb 14, 2023

SELL
$31.9 - $41.95 $272,043 - $357,749
-8,528 Reduced 96.35%
323 $12,000
Q3 2022

Nov 14, 2022

SELL
$29.83 - $38.01 $1.89 Million - $2.41 Million
-63,365 Reduced 87.74%
8,851 $284,000
Q2 2022

Aug 15, 2022

BUY
$23.09 - $33.46 $1.48 Million - $2.15 Million
64,228 Added 804.06%
72,216 $2.14 Million
Q1 2022

May 16, 2022

SELL
$26.91 - $47.15 $407,363 - $713,756
-15,138 Reduced 65.46%
7,988 $224,000
Q4 2021

Feb 14, 2022

SELL
$32.97 - $56.85 $311,896 - $537,801
-9,460 Reduced 29.03%
23,126 $1.07 Million
Q3 2021

Nov 15, 2021

SELL
$26.48 - $35.99 $143,601 - $195,173
-5,423 Reduced 14.27%
32,586 $1.07 Million
Q2 2021

Aug 16, 2021

SELL
$31.86 - $38.6 $360,018 - $436,180
-11,300 Reduced 22.92%
38,009 $1.33 Million
Q1 2021

May 17, 2021

SELL
$28.4 - $36.14 $526,195 - $669,601
-18,528 Reduced 27.31%
49,309 $1.78 Million
Q4 2020

Feb 16, 2021

BUY
$23.69 - $31.47 $846,988 - $1.13 Million
35,753 Added 111.44%
67,837 $1.97 Million
Q3 2020

Nov 16, 2020

BUY
$26.38 - $33.1 $846,375 - $1.06 Million
32,084 New
32,084 $905,000
Q2 2020

Aug 14, 2020

SELL
$29.93 - $50.1 $268,053 - $448,695
-8,956 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$30.35 - $67.14 $14,901 - $32,965
491 Added 5.8%
8,956 $365,000
Q4 2019

Feb 14, 2020

BUY
$55.65 - $79.83 $108,239 - $155,269
1,945 Added 29.83%
8,465 $522,000
Q2 2019

Aug 14, 2019

SELL
$67.77 - $82.2 $354,098 - $429,495
-5,225 Reduced 44.49%
6,520 $536,000
Q1 2019

May 15, 2019

SELL
$45.83 - $70.54 $113,475 - $174,657
-2,476 Reduced 17.41%
11,745 $0
Q4 2018

Feb 14, 2019

BUY
$41.17 - $56.44 $190,781 - $261,542
4,634 Added 48.34%
14,221 $640,000
Q3 2018

Nov 13, 2018

BUY
$52.95 - $71.34 $248,017 - $334,156
4,684 Added 95.53%
9,587 $0
Q1 2018

May 11, 2018

SELL
$56.98 - $72.41 $107,749 - $136,927
-1,891 Reduced 27.83%
4,903 $285,000
Q4 2017

Feb 09, 2018

SELL
$53.3 - $74.56 $79,097 - $110,647
-1,484 Reduced 17.93%
6,794 $438,000
Q3 2017

Nov 09, 2017

BUY
$43.46 - $52.49 $359,761 - $434,512
8,278
8,278 $435,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $945M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.